ARCHIVES

Phase II Elotuzumab Study Demonstrates 33 Months PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

DRCCA Committee, ACCC, DeVita Reach Agreement On CCOP

October 16, 1981

PHS Plans Revitalization of Commissioned Corps

July 11, 2003

DRCA Board Split On Use Of Cancer Control Funds By Centers; NCAB Probably Will Decide The Issue

November 26, 1982

Fountain Hearings Turn Up Some Responsible Criticism, some Not, Much Support for Program

June 24, 1977

New Treatment Approaches For A Variety Of Leukemias Described At ASH Meeting

January 30, 2004

DePinho Seeks New Review of Incubator Proposal

June 1, 2012